Specifically, the A/A genotype of MTRR rs1801394 combined with high vitamin B2 intake could have synergistic effects decreasing CRC risk in males, and homozygosity for the major allele (A) of the MTR rs1805087 polymorphism could interact with vitamin B2 to reduce CRC risk in males. This evidence concerns the gene MTR and colorectal carcinoma.